Alcohol abuse, 15, 93-99, 481

age of onset, 78

childhood interventions, 481, 548

and children, 4, 155, 159, 160, 176, 502

classification, 12, 93-95, 99

and control of availability, 159, 162-163, 267-268, 275, 479, 502, 512, 546

and depression, 96, 481, 502, 548

and domestic violence, 481, 548

economic costs, 4-5, 488

markers, 156-157, 162, 502

risk and protective factors, 154-163, 501-502

Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA), 27, 427, 464

funding, 438, 440-444, 449, 531

Alcohol Education Project, 265-266

ALERT Drug Prevention, 265

Alternative healing practices, 249, 340-344, 346-347, 348-349

Aluminum, and Alzheimer's disease, 138

Alzheimer's disease (AD), 4, 15, 105-111, 118, 291, 294, 488, 498

age of onset, 107, 111, 131

classification and diagnosis, 106, 108-109

delay of onset, 26, 118, 132-133, 137, 139, 141, 501

risk factors, 129-141, 501

treatment, 109-110, 141

American Academy of Child and Adolescent Psychiatry, 4

American Association of Retired Persons (AARP), 296

American Express Foundation, 449, 530

American Stop Smoking Intervention Trial (ASSIST), 40

Amyloid deposition, 118, 132-133, 134, 139, 141, 501

Annie E. Casey Foundation, 449, 531

Anthropology, 474, 540

Antisocial behavior, 84-86, 171-172, 176-177, 178, 179

Antisocial personality disorder, 82, 84-86, 96

and alcohol abuse, 96, 158, 162, 501-502

Anxiety, 13, 55, 87, 97, 104, 318, 319, 320

Applied behavior analysis, 477, 544

Applied research, 475, 542

Asian-Americans, 161, 394-395, 397, 524

Assertiveness Training Programs, 251

Asymptomatic individuals, 21, 22, 25, 494-495

Attachment, 63-64, 68, 161, 498

Attack rate, 76

Attention deficits, 83, 148

Attributable risk, 62, 75-76, 79-80, 115, 192, 497-498

Attrition and retention, of study participants, 221, 369, 389, 512, 522

Autism, 56-57, 559

B

Basic research, 54, 475, 476, 542, 543

Behaviorally Based Preventive Intervention, 270

Behavioral sciences, 53, 63-64, 67-68, 476, 496, 498, 542

Benchmark estimates, developmental studies, 476, 477, 543, 544, 546

Benefit-cost issues, see Cost-benefit analysis;

Cost effectiveness

Bereavement, see Loss and bereavement

Biochemical markers, 156

Biological factors, 5, 6, 61, 493, 494, 500, 501

alcohol abuse, 155-157

conduct disorder, 171-175, 180

depression, 163-165

interventions, 301, 512

research funding, 476, 478, 543, 545

schizophrenia, 142-149, 501



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement